Table 2.
Validation metrics.
| Metric | ACC/AHA ASCVD function (optimal threshold, 6.50%) | 2008 FHS global CVD function (Optimal threshold, 5.92%) |
|---|---|---|
| Sensitivity | 56.5% (95% CI, 46.4%-67.1%) | 69.6% (95% CI, 56.4%-80.8%) |
| Specificity | 49.4% (95% CI, 39.4%-59.0%) | 39.3% (95% CI, 29.6%-50.0%) |
| PPV | 36.6% (95% CI, 27.8%-45.3%) | 37.2% (95% CI, 26.7%,47.7%) |
| NPV | 64.9% (95% CI, 55.2%-73.8%) | 67.9% (95% CI, 58.1%-77.4%) |
ACC/AHA, American College of Cardiology/American Heart Association; ASCVD, atherosclerotic cardiovascular disease; FHS, Framingham Heart Study; CI, confidence interval; CVD, cardiovascular disease risk calculator; NPV, negative predictive value; PPV, positive predictive value.